C5 and COVID-19: Moreover, avdoralimab, a human Fc-silent monoclonal antibody against C5aR1, inhibited production of inflammatory cytokines, induced by either C5a or single strand RNA virus-like stimuli, by monocytes of patients with COVID-19 (8).